4DMedical Limited (4DX.AX)
AUD 0.46
(1.11%)
AUD 0.46
(1.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 3.75 Million AUD | 1230.44% |
| 2023 | 282.18 Thousand AUD | -73.24% |
| 2022 | 1.05 Million AUD | 385.9% |
| 2021 | 216.97 Thousand AUD | -82.4% |
| 2020 | 1.23 Million AUD | 77.34% |
| 2019 | 695 Thousand AUD | -11.94% |
| 2018 | 789.25 Thousand AUD | 40900.47% |
| 2017 | 1925.00 AUD | -99.45% |
| 2016 | 350.89 Thousand AUD | 38.8% |
| 2015 | 252.81 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 3.75 Million AUD | 1230.44% |
| 2024 Q1 | 396.25 Thousand AUD | 70.28% |
| 2024 Q4 | 1.48 Million AUD | 0.0% |
| 2024 Q2 | 792.5 Thousand AUD | 100.0% |
| 2024 Q3 | 1.48 Million AUD | 86.86% |
| 2023 Q3 | 116.35 Thousand AUD | -76.05% |
| 2023 FY | 282.18 Thousand AUD | -73.24% |
| 2023 Q1 | 242.93 Thousand AUD | -72.94% |
| 2023 Q4 | 232.71 Thousand AUD | 100.0% |
| 2023 Q2 | 485.86 Thousand AUD | 100.0% |
| 2022 Q1 | 78.3 Thousand AUD | 18.2% |
| 2022 Q2 | 156.61 Thousand AUD | 100.0% |
| 2022 Q4 | 897.68 Thousand AUD | 100.0% |
| 2022 FY | 1.05 Million AUD | 385.9% |
| 2022 Q3 | 448.84 Thousand AUD | 186.6% |
| 2021 Q3 | 33.12 Thousand AUD | -78.02% |
| 2021 FY | 216.97 Thousand AUD | -82.4% |
| 2021 Q2 | 150.72 Thousand AUD | 100.0% |
| 2021 Q1 | 75.36 Thousand AUD | -43.12% |
| 2021 Q4 | 66.25 Thousand AUD | 100.0% |
| 2020 Q1 | 550 Thousand AUD | 58.4% |
| 2020 Q3 | 66.25 Thousand AUD | -93.98% |
| 2020 Q4 | 132.5 Thousand AUD | 100.0% |
| 2020 FY | 1.23 Million AUD | 77.34% |
| 2020 Q2 | 1.1 Million AUD | 100.0% |
| 2019 Q4 | 347.21 Thousand AUD | 0.0% |
| 2019 Q2 | 285.00 AUD | 0.0% |
| 2019 Q1 | 285.00 AUD | 0.0% |
| 2019 FY | 695 Thousand AUD | -11.94% |
| 2019 Q3 | 347.21 Thousand AUD | 121730.18% |
| 2018 FY | 789.25 Thousand AUD | 40900.47% |
| 2017 FY | 1925.00 AUD | -99.45% |
| 2016 FY | 350.89 Thousand AUD | 38.8% |
| 2015 FY | 252.81 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Adherium Limited | 840.98 Thousand AUD | -346.413% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 94.074% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 8.131% |
| Anteris Technologies Ltd | 4.11 Million AUD | 8.68% |
| Control Bionics Limited | 5.12 Million AUD | 26.773% |
| CardieX Limited | 10.9 Million AUD | 65.575% |
| Compumedics Limited | 49.71 Million AUD | 92.449% |
| Cochlear Limited | 2.25 Billion AUD | 99.834% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 76.121% |
| Cyclopharm Limited | 27.13 Million AUD | 86.167% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 66.537% |
| Nova Eye Medical Limited | 23.32 Million AUD | 83.905% |
| HeraMED Limited | 402.89 Thousand AUD | -831.815% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -509.885% |
| ImpediMed Limited | 10.31 Million AUD | 63.618% |
| InhaleRx Limited | 1.2 Million AUD | -211.803% |
| LBT Innovations Limited | 1.25 Million AUD | -198.906% |
| Micro-X Limited | 15.22 Million AUD | 75.337% |
| Neurotech International Limited | 1963.00 AUD | -191150.942% |
| OncoSil Medical Limited | 1.56 Million AUD | -139.83% |
| PolyNovo Limited | 103.19 Million AUD | 96.362% |
| Respiri Limited | 456.91 Thousand AUD | -721.655% |
| SomnoMed Limited | 91.65 Million AUD | 95.904% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 43.399% |
| Uscom Limited | 3.72 Million AUD | -0.736% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 56.698% |